BioScience Health Innovations, Inc. (BHIC)
↓ Download CSV- Sector Services
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2025, BioScience Health Innovations, Inc. reported revenue of $5.69M, up 208.3% from the prior year. The company was profitable, with a net margin of 11.3% and a gross margin of 57.0%. It held $1.71M in total assets against $229.9K in total liabilities.
Key ratios (FY2025)
57.0%
Gross margin
12.6%
Operating margin
11.3%
Net margin
43.5%
Return on equity
+208.3%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $5.69M | $1.84M | $597.6K | $69.3K | $0 | $0 | — |
| Cost of Revenue | $2.45M | $536.1K | $113.2K | $9.7K | — | — | — |
| Gross Profit | $3.24M | $1.31M | $484.4K | $59.6K | — | — | — |
| Operating Income | $719.1K | $87.0K | -$251.5K | -$170.4K | -$25.6K | -$7.7K | — |
| Net Income | $642.1K | $87.0K | -$251.5K | -$170.4K | -$25.6K | -$7.7K | — |
| EPS (Diluted) | $0.06 | $0.01 | $-0.01 | — | — | — | — |
| Total Assets | $1.71M | $873.8K | $93.4K | $31.6K | $6.3K | $20.6K | $1.9K |
| Total Liabilities | $229.9K | $38.5K | $100.1K | $48.8K | $19.1K | $7.8K | $0 |
| Shareholders' Equity | $1.48M | $835.2K | -$6.8K | -$17.2K | -$1.0K | $12.8K | $1.9K |
| Cash & Equivalents | $661.9K | $662.5K | $19.2K | $11.6K | $2.0K | $20.6K | $0 |
| Operating Cash Flow | $172.2K | $23.2K | -$307.8K | -$182.8K | -$29.4K | -$7.7K | — |
| Shares Outstanding | 10.98M | 10.98M | 40.90M | 5.46M | 5.46M | 5.46M | 2.80M |